These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 29122139)
1. Role of Exercise Testing in Hypertrophic Cardiomyopathy. Rowin EJ; Maron BJ; Olivotto I; Maron MS JACC Cardiovasc Imaging; 2017 Nov; 10(11):1374-1386. PubMed ID: 29122139 [TBL] [Abstract][Full Text] [Related]
2. Upright treadmill vs. semi-supine bicycle exercise echocardiography to provoke obstruction in symptomatic hypertrophic cardiomyopathy: a pilot study. Reant P; Dufour M; Peyrou J; Reynaud A; Rooryck C; Dijos M; Vincent C; Cornolle C; Roudaut R; Lafitte S Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):31-38. PubMed ID: 28329285 [TBL] [Abstract][Full Text] [Related]
3. Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes. Desai MY; Bhonsale A; Patel P; Naji P; Smedira NG; Thamilarasan M; Lytle BW; Lever HM JACC Cardiovasc Imaging; 2014 Jan; 7(1):26-36. PubMed ID: 24290569 [TBL] [Abstract][Full Text] [Related]
4. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics. Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875 [TBL] [Abstract][Full Text] [Related]
5. Comparison of resting and exercise echocardiographic parameters as indicators of outcomes in hypertrophic cardiomyopathy. Reant P; Reynaud A; Pillois X; Dijos M; Arsac F; Touche C; Landelle M; Rooryck C; Roudaut R; Lafitte S J Am Soc Echocardiogr; 2015 Feb; 28(2):194-203. PubMed ID: 25459499 [TBL] [Abstract][Full Text] [Related]
6. Rest and latent obstruction in hypertrophic cardiomyopathy: impact on exercise tolerance. Re F; Zachara E; Avella A; Baratta P; Di Mauro M; Penco M; Musumeci F; Tondo C J Cardiovasc Med (Hagerstown); 2013 May; 14(5):372-9. PubMed ID: 22728835 [TBL] [Abstract][Full Text] [Related]
7. Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment. Finocchiaro G; Haddad F; Knowles JW; Caleshu C; Pavlovic A; Homburger J; Shmargad Y; Sinagra G; Magavern E; Wong M; Perez M; Schnittger I; Myers J; Froelicher V; Ashley EA JACC Heart Fail; 2015 May; 3(5):408-418. PubMed ID: 25863972 [TBL] [Abstract][Full Text] [Related]
8. Safety profile and utility of treadmill exercise in patients with high-gradient hypertrophic cardiomyopathy. Sorensen LL; Liang HY; Pinheiro A; Hilser A; Dimaano V; Olsen NT; Hansen TF; Sogaard P; Nowbar A; Pisanello C; Pozios I; Phillip S; Zhou X; Abraham R; Abraham TP Am Heart J; 2017 Feb; 184():47-54. PubMed ID: 27892886 [TBL] [Abstract][Full Text] [Related]
9. Aortic stiffness independently predicts exercise capacity in hypertrophic cardiomyopathy: a multimodality imaging study. Austin BA; Popovic ZB; Kwon DH; Thamilarasan M; Boonyasirinant T; Flamm SD; Lever HM; Desai MY Heart; 2010 Aug; 96(16):1303-10. PubMed ID: 20659950 [TBL] [Abstract][Full Text] [Related]
10. Tissue Doppler imaging during exercise stress echocardiography demonstrates a mechanism for impaired exercise performance in children with hypertrophic cardiomyopathy. Ferguson ME; Sachdeva R; Gillespie SE; Morrow G; Border W Echocardiography; 2016 Nov; 33(11):1718-1725. PubMed ID: 27545012 [TBL] [Abstract][Full Text] [Related]
15. Hemodynamic changes in systolic and diastolic function during isoproterenol challenge predicts symptomatic response to myectomy in hypertrophic cardiomyopathy with labile obstruction. Prasad M; Geske JB; Sorajja P; Ommen SR; Schaff HV; Gersh BJ; Nishimura RA Catheter Cardiovasc Interv; 2016 Nov; 88(6):962-970. PubMed ID: 27062082 [TBL] [Abstract][Full Text] [Related]
16. Dissecting functional impairment in hypertrophic cardiomyopathy by dynamic assessment of diastolic reserve and outflow obstruction: A combined cardiopulmonary-echocardiographic study. Re F; Zachara E; Avella A; Baratta P; di Mauro M; Uguccioni M; Olivotto I Int J Cardiol; 2017 Jan; 227():743-750. PubMed ID: 27839814 [TBL] [Abstract][Full Text] [Related]
17. Prognostic role of stress echocardiography in hypertrophic cardiomyopathy: The International Stress Echo Registry. Ciampi Q; Olivotto I; Gardini C; Mori F; Peteiro J; Monserrat L; Fernandez X; Cortigiani L; Rigo F; Lopes LR; Cruz I; Cotrim C; Losi M; Betocchi S; Beleslin B; Tesic M; Dikic AD; Lazzeroni E; Lazzeroni D; Sicari R; Picano E Int J Cardiol; 2016 Sep; 219():331-8. PubMed ID: 27348413 [TBL] [Abstract][Full Text] [Related]
18. The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy. Maron BJ; Maron MS; Wigle ED; Braunwald E J Am Coll Cardiol; 2009 Jul; 54(3):191-200. PubMed ID: 19589431 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of dobutamine stress echocardiography and exercise echocardiography in evaluating left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy]. Shao CL; Duan FJ; Qiao SB; You SJ; Hu FH; Yuan JS; Yang WX Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Mar; 40(3):214-8. PubMed ID: 22801266 [TBL] [Abstract][Full Text] [Related]
20. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Maron MS; Olivotto I; Zenovich AG; Link MS; Pandian NG; Kuvin JT; Nistri S; Cecchi F; Udelson JE; Maron BJ Circulation; 2006 Nov; 114(21):2232-9. PubMed ID: 17088454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]